(19)
(11) EP 4 798 170 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883275.0

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
A61K 9/127(2025.01)
C12N 15/88(2006.01)
A61K 47/55(2017.01)
A61K 48/00(2006.01)
C12N 15/113(2010.01)
A61K 31/7088(2006.01)
A61K 47/60(2017.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/88; A61K 48/0025; A61K 48/0041; A61K 48/0091; A61K 31/711; A61K 47/549; A61K 47/6929; A61K 47/62; A61K 45/06; A61K 9/5123
(86) International application number:
PCT/US2024/052650
(87) International publication number:
WO 2025/090663 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.10.2023 US 202363592852 P
01.12.2023 WO PCT/US2023/082037
18.09.2024 US 202463696269 P

(71) Applicant: Generation Bio Co.
Cambridge, Massachusetts 02142 (US)

(72) Inventors:
  • STANTON, Mattthew, G.
    Cambridge, MA 02142 (US)
  • ROSE, Douglas, A.
    Cambridge, MA 02142 (US)
  • SHAH, Sachit
    Cambridge, MA 02142 (US)
  • SYROVATKINA, Viktoriya
    Cambridge, MA 02142 (US)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) NOVEL POLYGLYCEROL-CONJUGATED LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS COMPRISING THE SAME